Skip to main content
S 3180 116th Congress Senate Health Drug safety, medical device, and laboratory regulation Marketing and advertising Prescription drugs

Responsibility in Drug Advertising Act of 2020

Introduced: January 9, 2020 Introduced by: King, Angus S., Jr. Independent · Maine See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 9, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jan 9, 2020
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Responsibility in Drug Advertising Act of 2020

This bill prohibits direct-to-consumer advertising of a drug in the first three years after the drug's approval. The Food and Drug Administration may (1) waive the third year of this prohibition for a drug if direct-to-consumer advertising of the drug would have an affirmative value to public health, or (2) extend the prohibition if the drug has significant adverse health effects.
What's happening now January 9, 2020

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 2
  • HR 2452 Related bill Medicare for America Act of 2019
  • HR 4106 Identical bill Responsibility in Drug Advertising Act of 2019
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 3180: Responsibility in Drug Advertising Act of 2020. 116th Congress. Open America. https://openamerica.io/bill/116-S-3180/
MLA
"S. 3180: Responsibility in Drug Advertising Act of 2020." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-3180/.
Bluebook (legal)
S. 3180, 116th Cong. (2026), https://openamerica.io/bill/116-S-3180/.
Markdown link
[S. 3180: Responsibility in Drug Advertising Act of 2020](https://openamerica.io/bill/116-S-3180/)
Report a problem